Number needed to treat: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
| Line 15: | Line 15: | ||
==Worked example== | ==Worked example== | ||
{{ARR RRR worksheet}} | {{ARR RRR worksheet}} | ||
==Variations== | |||
===Number needed to screen=== | |||
In [[Screening (medicine)| screening]], the number needed to screen is the number of patients who must be screened for one patient to benefit.<ref name="pmid11678550">{{cite journal| author=Richardson A| title=Screening and the number needed to treat. | journal=J Med Screen | year= 2001 | volume= 8 | issue= 3 | pages= 125-7 | pmid=11678550 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11678550 }} </ref> | |||
===Number needed to invite=== | |||
In [[Screening (medicine)| screening]], the number needed to invite, is the number needed to screen divided by the rate of acceptance of screening.<ref name="pmid11678550">{{cite journal| author=Richardson A| title=Screening and the number needed to treat. | journal=J Med Screen | year= 2001 | volume= 8 | issue= 3 | pages= 125-7 | pmid=11678550 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11678550 }} </ref> | |||
==See also== | ==See also== | ||
Revision as of 00:40, 25 September 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The number needed to treat (NNT) is an epidemiological measure that indicates how many patients would require treatment with a form of medication to reduce the expected number of cases of a defined endpoint by one. It is defined as the inverse of the absolute risk reduction. It was described in 1988.[1]
For example, consider a hypothetical drug which reduces the risk of colon cancer by 50%. Even without the drug, colon cancer is fairly rare, maybe 1 in 3,000 in every 5 year period. The NNT for a 5-year treatment with the drug is therefore 6,000: by treating 6,000 people with the drug, one can expect to reduce the number of colon cancer cases from 2 to 1.
In general, NNT is always computed with respect to two treatments A and B, with A typically a drug and B a placebo (in our example above, A is a 5-year treatment with the hypothetical drug, and B is no treatment). A defined endpoint has to be specified (in our example: the appearance of colon cancer in the 5 year period). If the probabilities pA and pB of this endpoint under treatments A and B, respectively, are known, then the NNT is computed as 1/(pB-pA).
The NNT is an important measure in pharmacoeconomics. If a clinical endpoint is devastating enough (e.g. death, heart attack), drugs with a high NNT may still be indicated in particular situations. If the endpoint is minor, health insurers may decline to reimburse drugs with a high NNT.
Worked example
Variations
Number needed to screen
In screening, the number needed to screen is the number of patients who must be screened for one patient to benefit.[2]
Number needed to invite
In screening, the number needed to invite, is the number needed to screen divided by the rate of acceptance of screening.[2]
See also
- Number needed to harm - the converse for side-effects